Alterations of karyotype and oncogenicity in mouse myeloma MOPC-315 and 5-bromodeoxyuridine-resistant cell lines. 1974

J S Shepard, and O S Pettengill, and D H Wurster-Hill, and G D Sorenson

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D010954 Plasmacytoma Any discrete, presumably solitary, mass of neoplastic PLASMA CELLS either in BONE MARROW or various extramedullary sites. Plasma Cell Tumor,Plasmocytoma,Plasma Cell Tumors,Plasmacytomas,Plasmocytomas,Tumor, Plasma Cell,Tumors, Plasma Cell
D001973 Bromodeoxyuridine A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors. BUdR,BrdU,Bromouracil Deoxyriboside,Broxuridine,5-Bromo-2'-deoxyuridine,5-Bromodeoxyuridine,NSC-38297,5 Bromo 2' deoxyuridine,5 Bromodeoxyuridine,Deoxyriboside, Bromouracil
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D003434 Crossing Over, Genetic The reciprocal exchange of segments at corresponding positions along pairs of homologous CHROMOSOMES by symmetrical breakage and crosswise rejoining forming cross-over sites (HOLLIDAY JUNCTIONS) that are resolved during CHROMOSOME SEGREGATION. Crossing-over typically occurs during MEIOSIS but it may also occur in the absence of meiosis, for example, with bacterial chromosomes, organelle chromosomes, or somatic cell nuclear chromosomes. Crossing Over,Crossing-Over, Genetic,Crossing Overs,Genetic Crossing Over,Genetic Crossing-Over

Related Publications

J S Shepard, and O S Pettengill, and D H Wurster-Hill, and G D Sorenson
March 1981, International journal of cancer,
J S Shepard, and O S Pettengill, and D H Wurster-Hill, and G D Sorenson
January 1974, Biochemistry,
J S Shepard, and O S Pettengill, and D H Wurster-Hill, and G D Sorenson
March 1980, Journal of immunology (Baltimore, Md. : 1950),
J S Shepard, and O S Pettengill, and D H Wurster-Hill, and G D Sorenson
October 1978, Biochemistry,
J S Shepard, and O S Pettengill, and D H Wurster-Hill, and G D Sorenson
January 1973, Journal of surgical oncology,
J S Shepard, and O S Pettengill, and D H Wurster-Hill, and G D Sorenson
December 1982, Journal of immunology (Baltimore, Md. : 1950),
J S Shepard, and O S Pettengill, and D H Wurster-Hill, and G D Sorenson
November 1973, International journal of cancer,
J S Shepard, and O S Pettengill, and D H Wurster-Hill, and G D Sorenson
January 1974, Immunological communications,
J S Shepard, and O S Pettengill, and D H Wurster-Hill, and G D Sorenson
January 1981, Journal of immunology (Baltimore, Md. : 1950),
J S Shepard, and O S Pettengill, and D H Wurster-Hill, and G D Sorenson
October 1977, Journal of the National Cancer Institute,
Copied contents to your clipboard!